Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by EquityInveston May 27, 2018 5:43pm
227 Views
Post# 28086469

RE:what will it take for ACB to become a 50 dollar stock??

RE:what will it take for ACB to become a 50 dollar stock??
Easymoney123 wrote: How much revenue would ACB have to make for it to become a 50 dollar stock?  Just wondering what people think a company like ACB would have to do to hit 50 dollars.  I think if the European medical market becomes as big as they are predicting with in 5 years plus new markets opening up I think ACB at full production of 570,000 kg 72,000 litres of oils could generate 5 billion dollars a year.  Would that be enough to get the share price to 50 dollars?  Interested in seeing what people’s opinions are on what it would take to get to 50 dollars?


Easymoney123, there is a lot of factors that affect the sp (business value, investor expectations, supply and demand, momentum, etc.).  We need to set parameters so we can "speculate" on what ACB needs to do to "reach" a $50 share price:  legalization is a done deal;  ACB's outstanding shares, including outstanding warrants and options = 1 billion shares; and mj industry's average price-per-sale is 100:1 (to accomodate the $5B revenue case).

ACB will have to continue to grow its revenue - pharma, liquor, tobacco, etc; reduce its production and administrative costs (economies of scale should start to kick-in with the acquisitions of CMED and LEAF); show profit and pay out dividends; and STOP issuing shares.

Shortest route to this is for ACB to be acquired by a conglomerate corporation! (This is our best hope!)

GLTA 


Bullboard Posts